Systemic therapy in soft tissue sarcomas: past, present and future.

Item

http://www.wikidata.org/entity/Q38064436

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Systemic therapy in soft tissue sarcomas: past, present and future.

@en

type

Item

label

Systemic therapy in soft tissue sarcomas: past, present and future.

@en

prefLabel

Systemic therapy in soft tissue sarcomas: past, present and future.

@en

P1476

Systemic therapy in soft tissue sarcomas: past, present and future.

@en

P2093

K C Lakshmaiah

http://www.w3.org/2001/XMLSchema#string

K Govindbabu

http://www.w3.org/2001/XMLSchema#string

Rohan Bhise

http://www.w3.org/2001/XMLSchema#string

Samit Purohit

http://www.w3.org/2001/XMLSchema#string

Sandhya Appachu

http://www.w3.org/2001/XMLSchema#string

P2860

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.

P2888

s13193-012-0140-8

P304

327-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S13193-012-0140-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233830704

http://www.w3.org/2001/XMLSchema#string

P6179

1032261742

http://www.w3.org/2001/XMLSchema#string

P698

23204790

http://www.w3.org/2001/XMLSchema#string

P932

3338141

http://www.w3.org/2001/XMLSchema#string